Clinical Trial Update: Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study examines how a high-fat meal influences the pharmacokinetics of SHR3824 and includes a mass balance assessment in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED